These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3927788)

  • 1. Antithrombotic potential of pentoxifylline. A hemorheologically active drug.
    Schröer RH
    Angiology; 1985 Jun; 36(6):387-98. PubMed ID: 3927788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hemocoagulation, fibrinolytic and rheologic parameters in ischemic vasculopathy. Effects of pentoxifylline in the treatment of acute cerebral vasculopathy].
    Muggeo M; Calabrò A; Businaro V; Patussi L; Volpe A; Signorini GP; Crepaldi G
    Ric Clin Lab; 1981; 11 Suppl 1():353-71. PubMed ID: 7188124
    [No Abstract]   [Full Text] [Related]  

  • 3. Haemorheological role of platelet aggregation and hypercoagulability in microcirculation: therapeutical approach with pentoxifylline.
    Müller R; Lebrach F
    Pharmatherapeutica; 1980; 2(6):372-9. PubMed ID: 7001492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic effects of acetylsalicylic acid (ASA) and pentoxifylline in laser-induced thrombosis in rat mesenteric vessels.
    Weichert W; Breddin HK
    Vasa; 1985; 14(3):280-4. PubMed ID: 3840307
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug stimulated prostacyclin release.
    Weithmann KU
    Ric Clin Lab; 1981; 11 Suppl 1():209-14. PubMed ID: 6324324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulatory effects of vascular prostaglandins on the antiaggregatory activities of pentoxifylline acetylsalicylic acid combinations in vitro.
    Weithmann KU; Just M; Schlotte V; Seiffge D
    Vasa; 1989; 18(4):273-6. PubMed ID: 2514520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced platelet aggregation by effects of pentoxifylline on vascular prostacyclin isomerase and platelet cyclic AMP.
    Weithmann KU
    Gen Pharmacol; 1983; 14(1):161-2. PubMed ID: 6298055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemorheology in surgery--a review.
    Müller R; Musikić P
    Angiology; 1987 Aug; 38(8):581-92. PubMed ID: 3307545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced thrombus formation in vivo after administration of pentoxifylline (Trental).
    Michal M; Giessinger N; Schröer R
    Thromb Res; 1989 Nov; 56(3):359-68. PubMed ID: 2617475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pentoxifylline and prostaglandins].
    Poggesi L; Boddi M; Scarti L; Masotti G
    Ric Clin Lab; 1988; 18 Suppl 2():37-46. PubMed ID: 2854659
    [No Abstract]   [Full Text] [Related]  

  • 11. Reduced platelet aggregation by pentoxifylline stimulated prostacyclin release.
    Weithmann KU
    Vasa; 1981; 10(3):249-52. PubMed ID: 7025499
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet resistance to prostacyclin. Enhancement of the antiaggregatory effect of prostacyclin by pentoxifylline.
    Manrique RV; Manrique V
    Angiology; 1987 Feb; 38(2 Pt 1):101-8. PubMed ID: 3030162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The release of prostacyclin (PGI2) by pentoxifylline from human vascular tissue.
    Matzky R; Darius H; Schrör K
    Arzneimittelforschung; 1982; 32(10):1315-8. PubMed ID: 6817760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of the potentiation of thrombolysis by pentoxifylline (Trental).
    Ambrus JL; Ambrus CM; Mahfzah M; Markus JA; Klein E; Gastpar H
    J Med; 1987; 18(5-6):265-76. PubMed ID: 3505256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The biology of fibrinogen. The role of pentoxifylline].
    Soria J; Soria C
    J Mal Vasc; 1989; 14 Suppl A():25-8. PubMed ID: 2654312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial results of pentoxifylline ('Trental') therapy in arteriosclerosis obliterans: possible mechanism of action.
    Kostka-Trabkowa E; Dembińska-Kieć A; Grodzińska L; Bieroń K; Gryglewski RJ
    Curr Med Res Opin; 1985; 9(6):407-15. PubMed ID: 3886306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis.
    Poggesi L; Scarti L; Boddi M; Masotti G; Serneri GG
    Angiology; 1985 Sep; 36(9):628-37. PubMed ID: 3901827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on platelet aggregation with pentoxifylline: effect on neoplastic disorders and other new indications.
    Ambrus JL; Ambrus CM; Gastpar H
    J Med; 1979; 10(5):339-45. PubMed ID: 119023
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on platelet aggregation inhibitors in vivo. X. Relationship to thrombolysis.
    Ambrus JL; Ambrus CM; Sharma SD; Suh OW; Gastpar H
    J Med; 1982; 13(5-6):365-71. PubMed ID: 6221055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of platelet aggregation in vivo. III. Effect of pentoxifylline.
    Gastpar H; Ambrus JL; Ambrus CM; Spavento P; Weber FJ; Thurber LE
    J Med; 1977; 8(3-4):191-7. PubMed ID: 407320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.